Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Doxazosin alone or versus in combination with celecoxib in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.

Next Previous
Trial Profile

Doxazosin alone or versus in combination with celecoxib in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 20 Jul 2012

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Celecoxib (Primary) ; Doxazosin
  • Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
  • Focus Therapeutic Use

Most Recent Events

  • 20 Jul 2012 New trial record
  • 24 May 2012 Results presented at the 107th Annual Meeting of the American Urological Association.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top